Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
Clinical trial NCT01869634 · COMPLETED
Trial details
- NCT number
- NCT01869634
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.